[Skip to Navigation]
Comment & Response
February 4, 2021

Long-term Macular Effects of Pentosan Polysulfate Sodium Exposure Uncertain—Let’s Not Jump to Conclusions—Reply

Author Affiliations
  • 1Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia
JAMA Ophthalmol. 2021;139(3):364-365. doi:10.1001/jamaophthalmol.2020.6618

In Reply We thank Vander for his insightful comments on our study of pentosan polysulfate (PPS) maculopathy.1 We agree with the general sentiment, particularly with the statements regarding the seriousness of this public health issue and the importance of being careful in drawing conclusions from the data. As Vander suggested, our report on disease course after drug cessation has clinical and medicolegal ramifications. More importantly, affected patients eagerly await information about long-term visual prognosis, and we wish to provide them with accurate information.

Add or change institution